> top > docs > PubMed:22097094 > annotations

PubMed:22097094 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-166 Sentence denotes Expression of epidermal growth factor receptor tyrosine kinase family in fine needle aspiration and permanent specimens of invasive lobular and ductal breast cancers.
TextSentencer_T2 167-274 Sentence denotes Recently, the role of HER-2/Neu gene amplification has been enthusiastically investigated in breast cancer.
TextSentencer_T3 275-430 Sentence denotes Determining the HER-2/Neu status could be achieved by evaluating either histologic samples or cytologic specimens obtained by Fine Needle Aspiration (FNA).
TextSentencer_T4 431-534 Sentence denotes This study aimed at determining the concordance of HER-2/Neu expression in FNA and histologic sections.
TextSentencer_T5 535-705 Sentence denotes FNA samples, as well as their corresponding histologic sections of 90 cases with breast cancer were evaluated in Tabriz Sina Teaching Center in a 13-month period of time.
TextSentencer_T6 706-805 Sentence denotes The immunohistochemistry was employed for determining the HER-2/Neu amplification for both methods.
TextSentencer_T7 806-881 Sentence denotes The concordance rate and agreement were determined between the two methods.
TextSentencer_T8 882-971 Sentence denotes Ninety specimens of women with a mean age of 50.93 +/- 10.64 (29-84) years were assessed.
TextSentencer_T9 972-1067 Sentence denotes There were 84 cases with invasive ductal carcinoma and 6 cases with invasive lobular carcinoma.
TextSentencer_T10 1068-1186 Sentence denotes Lymph nodes were involved in 50 cases and there were vascular and neural involvement in 40 and 35 cases, respectively.
TextSentencer_T11 1187-1334 Sentence denotes Her-2/Neu was not detected in 27 cases (30%) with weak and strong amplifications in 47 (52.2%) and 16 (17.8%) cases of FNA specimens, respectively.
TextSentencer_T12 1335-1491 Sentence denotes Her-2/Neu was not detected in 29 cases (32.2%) with weak and strong amplifications in 42 (46.7%) and 19 (21.1%) cases of histologic specimens, respectively.
TextSentencer_T13 1492-1545 Sentence denotes The concordance rate was 70% between the two methods.
TextSentencer_T14 1546-1650 Sentence denotes The agree ment was statistically significant between the two methods, as well (kappa = 0.51, p < 0.001).
TextSentencer_T15 1651-1840 Sentence denotes HER-2/neu gene amplification can be reliably estimated by immunohistochemistry on breast cancer FNAs and a good correlation has been found between this and results on histological sections.
T1 0-166 Sentence denotes Expression of epidermal growth factor receptor tyrosine kinase family in fine needle aspiration and permanent specimens of invasive lobular and ductal breast cancers.
T2 167-274 Sentence denotes Recently, the role of HER-2/Neu gene amplification has been enthusiastically investigated in breast cancer.
T3 275-430 Sentence denotes Determining the HER-2/Neu status could be achieved by evaluating either histologic samples or cytologic specimens obtained by Fine Needle Aspiration (FNA).
T4 431-534 Sentence denotes This study aimed at determining the concordance of HER-2/Neu expression in FNA and histologic sections.
T5 535-705 Sentence denotes FNA samples, as well as their corresponding histologic sections of 90 cases with breast cancer were evaluated in Tabriz Sina Teaching Center in a 13-month period of time.
T6 706-805 Sentence denotes The immunohistochemistry was employed for determining the HER-2/Neu amplification for both methods.
T7 806-881 Sentence denotes The concordance rate and agreement were determined between the two methods.
T8 882-971 Sentence denotes Ninety specimens of women with a mean age of 50.93 +/- 10.64 (29-84) years were assessed.
T9 972-1067 Sentence denotes There were 84 cases with invasive ductal carcinoma and 6 cases with invasive lobular carcinoma.
T10 1068-1186 Sentence denotes Lymph nodes were involved in 50 cases and there were vascular and neural involvement in 40 and 35 cases, respectively.
T11 1187-1334 Sentence denotes Her-2/Neu was not detected in 27 cases (30%) with weak and strong amplifications in 47 (52.2%) and 16 (17.8%) cases of FNA specimens, respectively.
T12 1335-1491 Sentence denotes Her-2/Neu was not detected in 29 cases (32.2%) with weak and strong amplifications in 42 (46.7%) and 19 (21.1%) cases of histologic specimens, respectively.
T13 1492-1545 Sentence denotes The concordance rate was 70% between the two methods.
T14 1546-1650 Sentence denotes The agree ment was statistically significant between the two methods, as well (kappa = 0.51, p < 0.001).
T15 1651-1840 Sentence denotes HER-2/neu gene amplification can be reliably estimated by immunohistochemistry on breast cancer FNAs and a good correlation has been found between this and results on histological sections.

DisGeNET

Id Subject Object Predicate Lexical cue
T0 189-198 gene:2064 denotes HER-2/Neu
T1 260-273 disease:C0006142 denotes breast cancer
T2 189-198 gene:2064 denotes HER-2/Neu
T3 260-273 disease:C0678222 denotes breast cancer
R1 T0 T1 associated_with HER-2/Neu,breast cancer
R2 T2 T3 associated_with HER-2/Neu,breast cancer

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 260-273 HP_0003002 denotes breast cancer
T2 260-273 HP_0100013 denotes breast cancer
T3 267-273 HP_0002664 denotes cancer
T4 413-423 HP_0002835 denotes Aspiration
T5 616-629 HP_0003002 denotes breast cancer
T6 616-629 HP_0100013 denotes breast cancer
T7 623-629 HP_0002664 denotes cancer
T8 1121-1152 HP_0002597 denotes vascular and neural involvement
T9 1733-1746 HP_0003002 denotes breast cancer
T10 1733-1746 HP_0100013 denotes breast cancer
T11 1740-1746 HP_0002664 denotes cancer

Allie

Id Subject Object Predicate Lexical cue
SS1_22097094_2_0 401-423 expanded denotes Fine Needle Aspiration
SS2_22097094_2_0 425-428 abbr denotes FNA
AE1_22097094_2_0 SS1_22097094_2_0 SS2_22097094_2_0 abbreviatedTo Fine Needle Aspiration,FNA

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
22097094-14#0#9#gene2064 1651-1660 gene2064 denotes HER-2/neu
22097094-14#82#95#diseaseC0006142 1733-1746 diseaseC0006142 denotes breast cancer
0#9#gene206482#95#diseaseC0006142 22097094-14#0#9#gene2064 22097094-14#82#95#diseaseC0006142 associated_with HER-2/neu,breast cancer

DisGeNet-2017-sample

Id Subject Object Predicate Lexical cue
T280 1651-1660 gene:2064 denotes HER-2/neu
T281 1733-1746 disease:C0006142 denotes breast cancer
R1 T280 T281 associated_with HER-2/neu,breast cancer

UBERON-AE

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 151-157 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T2 260-266 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T3 616-622 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T4 1733-1739 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 1068-1073 http://purl.obolibrary.org/obo/UBERON_0002391 denotes Lymph
PD-UBERON-AE-B_T2 1068-1079 http://purl.obolibrary.org/obo/UBERON_0000029 denotes Lymph nodes
PD-UBERON-AE-B_T3 151-157 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T4 260-266 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T5 616-622 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T6 1733-1739 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast